BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 21830924)

  • 1. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
    Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
    J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian statistics in medical devices: innovation sparked by the FDA.
    Campbell G
    J Biopharm Stat; 2011 Sep; 21(5):871-87. PubMed ID: 21830920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with reviewing Bayesian medical device trials.
    Pennello G; Thompson L
    J Biopharm Stat; 2008; 18(1):81-115. PubMed ID: 18161543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical Bayesian design and analysis for drug and device clinical trials.
    Hobbs BP; Carlin BP
    J Biopharm Stat; 2008; 18(1):54-80. PubMed ID: 18161542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical and regulatory issues in nonrandomized medical device clinical studies.
    Li H; Yue LQ
    J Biopharm Stat; 2008; 18(1):20-30. PubMed ID: 18161539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missing data in the regulation of medical devices.
    Campbell G; Pennello G; Yue L
    J Biopharm Stat; 2011 Mar; 21(2):180-95. PubMed ID: 21390995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical device development: from prototype to regulatory approval.
    Kaplan AV; Baim DS; Smith JJ; Feigal DA; Simons M; Jefferys D; Fogarty TJ; Kuntz RE; Leon MB
    Circulation; 2004 Jun; 109(25):3068-72. PubMed ID: 15226221
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistical innovations in the medical device world sparked by the FDA.
    Campbell G; Yue LQ
    J Biopharm Stat; 2016; 26(1):3-16. PubMed ID: 26372890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceuticals and medical devices: medical devices. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-25. PubMed ID: 20217916
    [No Abstract]   [Full Text] [Related]  

  • 12. Design and evaluation of multiregional trials with heterogeneous treatment effect across regions.
    Chen CT; Hung HM; Hsiao CF
    J Biopharm Stat; 2012 Sep; 22(5):1037-50. PubMed ID: 22946948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When to conduct a clinical trial.
    Boutrand JP
    Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectives.
    Liu Q; Chi GY
    J Biopharm Stat; 2010 Nov; 20(6):1178-219. PubMed ID: 21058114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful recruitment for medical device clinical studies.
    Donawa M
    Med Device Technol; 2004 Oct; 15(8):25-7. PubMed ID: 16225270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
    Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian approach for inference from a bridging study with binary outcomes.
    Gandhi M; Mukherjee B; Biswas D
    J Biopharm Stat; 2012 Sep; 22(5):935-51. PubMed ID: 22946941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA medical device approval: things you didn't learn in medical school or residency.
    Buch B
    Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.